Skip to content

Symax International Study

5 Year Clinical and Radiographic Follow-up of the Uncemented Symax Hip Stem in an International Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03469687
Enrollment
80
Registered
2018-03-19
Start date
2004-11-02
Completion date
2010-10-11
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis, Prosthesis Durability

Brief summary

The uncemented Symax hip stem is developed through optimization of the uncemented Omnifit hip stem. The Symax stem design combines an anatomical anteverted proximal geometry with a straight distal section. The proximal part is coated with a biomimetic hydroxyapatite (HA) coating for improved osseointegration to enhance load transfer and to minimize proximal bone loss. The distal part is treated with an anodization surface treatment in order to prevent distal bone apposition, which is expected to prevent distal loading and reduce proximal stress shielding. Aim of this study is to report mid-term clinical performance and evaluate whether the radiographic features are in line with the design principles of the Symax hip in an international clinical study with 5 years of follow-up.

Interventions

DEVICESymax uncemented hip stem

Sponsors

Vejle Hospital
CollaboratorOTHER
Stryker Orthopaedics
CollaboratorINDUSTRY
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients requiring uncemented primary total hip arthroplasty (osteoarthritis, avascular necrosis and/or post-traumatic arthritis), age between 18-70 years, BMI less or equal to 35.

Exclusion criteria

* Patients with bilateral hip complaints, impaired cognitive function and use of medication or illness influencing bone metabolism.

Design outcomes

Primary

MeasureTime frameDescription
Change of Harris Hip Score (HHS) during follow-upPreoperative HHS and postoperatively change in HHS at 6 months, 1 year, 2 years, 3 years and 5 yearsA hip specific functional score

Secondary

MeasureTime frameDescription
Radiographic evaluationsImmediately postoperative radiograhpic evaluation as baseline and changes in radiography at follow-up 6 months, 1 year, 2 years, 3 years and 5 years we evaluated the radiograhip evaluations againRadiographic evaluations per Gruen zone and comparison between two assessment teams

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026